| Yale Podiatry Group Pc | |
|
364 E Main St, Yale Podiatry Group Pc, Ansonia, CT 06401-1904 | |
| (203) 734-4806 | |
| (203) 734-8265 |
| Full Name | Yale Podiatry Group Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 364 E Main St, Ansonia, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184635237 | NPI | - | NPPES |
| 4020517 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Yale Podiatry Group Pc 364 E Main St, Yale Podiatry Group Pc, Ansonia, CT 06401-1904 Ph: (203) 734-4806 | Yale Podiatry Group Pc 364 E Main St, Yale Podiatry Group Pc, Ansonia, CT 06401-1904 Ph: (203) 734-4806 |
News Archive
The University of Michigan Health System has just embarked on a multi-year journey to completely transform the way its physicians, nurses, other care providers and administrators use information technology in every U-M hospital, clinic and office.
BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI).
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.
The definition of depression is proposed to be changed and now the diagnosis would characterize grieving as a disorder and greatly increase the number of people treated for it.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
› Verified 3 days ago
Yale Podiatry Group Podiatrist Medicare: Medicare Enrolled Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Jeffrey F Yale, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Michael S Travisano, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Mithun Sivadasan, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 |